Literature DB >> 17046758

A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein.

Huei-Ju Pan1, Diana S Agate, Benjamin L King, Michele K Wu, Steven L Roderick, Edward H Leiter, David E Cohen.   

Abstract

New Zealand obese (NZO/HlLt) male mice develop polygenic diabetes and altered phosphatidylcholine metabolism. The gene encoding phosphatidylcholine transfer protein (PC-TP) is sited within the support interval for Nidd3, a recessive NZO-derived locus on Chromosome 11 identified by prior segregation analysis between NZO/HlLt and NON/Lt. Sequence analysis revealed that the NZO-derived PC-TP contained a non-synonymous point mutation that resulted in an Arg120His substitution, which was shared by the related NZB/BlNJ and NZW/LacJ mouse strains. Consistent with the structure-based predictions, functional studies demonstrated that Arg120His PC-TP was inactive, suggesting that this mutation contributes to the deficiencies in phosphatidylcholine metabolism observed in NZO mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046758      PMCID: PMC1693963          DOI: 10.1016/j.febslet.2006.09.066

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

Review 1.  StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism.

Authors:  Raymond E Soccio; Jan L Breslow
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

2.  Phosphatidylcholine transfer protein promotes apolipoprotein A-I-mediated lipid efflux in Chinese hamster ovary cells.

Authors:  Juan M Baez; Suzanne E Barbour; David E Cohen
Journal:  J Biol Chem       Date:  2001-12-19       Impact factor: 5.157

3.  Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.

Authors:  Steven M Watkins; Peter R Reifsnyder; Huei-ju Pan; J Bruce German; Edward H Leiter
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

4.  Structure and lipid transport mechanism of a StAR-related domain.

Authors:  Y Tsujishita; J H Hurley
Journal:  Nat Struct Biol       Date:  2000-05

5.  Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein.

Authors:  D E Cohen; R M Green; M K Wu; D R Beier
Journal:  Biochim Biophys Acta       Date:  1999-10-28

6.  Origin of inbred NZ mouse strains.

Authors:  M Bielschowsky; C M Goodall
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

7.  High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: evidence for a C-terminal membrane binding domain.

Authors:  L Feng; W W Chan; S L Roderick; D E Cohen
Journal:  Biochemistry       Date:  2000-12-19       Impact factor: 3.162

8.  Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice.

Authors:  Peter C Reifsnyder; Edward H Leiter
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

9.  Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi.

Authors:  J Shoda; K Oda; H Suzuki; Y Sugiyama; K Ito; D E Cohen; L Feng; J Kamiya; Y Nimura; H Miyazaki; M Kano; Y Matsuzaki; N Tanaka
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

10.  Structure of human phosphatidylcholine transfer protein in complex with its ligand.

Authors:  Steven L Roderick; Wayne W Chan; Diana S Agate; Laurence R Olsen; Matt W Vetting; K R Rajashankar; David E Cohen
Journal:  Nat Struct Biol       Date:  2002-07
View more
  10 in total

Review 1.  PC-TP/StARD2: Of membranes and metabolism.

Authors:  Hye Won Kang; Jie Wei; David E Cohen
Journal:  Trends Endocrinol Metab       Date:  2010-03-24       Impact factor: 12.015

2.  Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling.

Authors:  Baran A Ersoy; Akansha Tarun; Katharine D'Aquino; Nancy J Hancer; Chinweike Ukomadu; Morris F White; Thomas Michel; Brendan D Manning; David E Cohen
Journal:  Sci Signal       Date:  2013-07-30       Impact factor: 8.192

3.  Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production.

Authors:  Ekaterina Y Shishova; Janis M Stoll; Baran A Ersoy; Sudeep Shrestha; Erez F Scapa; Yingxia Li; Michele W Niepel; Ya Su; Linda A Jelicks; Gregory L Stahl; Marcie A Glicksman; Roger Gutierrez-Juarez; Gregory D Cuny; David E Cohen
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

Review 4.  Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.

Authors:  Keishi Kanno; Michele K Wu; Erez F Scapa; Steven L Roderick; David E Cohen
Journal:  Biochim Biophys Acta       Date:  2007-04-12

5.  S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis.

Authors:  Nermina Malanovic; Ingo Streith; Heimo Wolinski; Gerald Rechberger; Sepp D Kohlwein; Oksana Tehlivets
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

6.  Skeletal muscle mitochondrial uncoupling prevents diabetes but not obesity in NZO mice, a model for polygenic diabesity.

Authors:  Anja Voigt; Yvonne Katterle; Melanie Kahle; Reinhart Kluge; Annette Schürmann; Hans-Georg Joost; Susanne Klaus
Journal:  Genes Nutr       Date:  2015-11-19       Impact factor: 5.523

Review 7.  The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models.

Authors:  Hans-Georg Joost; Annette Schürmann
Journal:  Mamm Genome       Date:  2014-04-22       Impact factor: 2.957

8.  Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations.

Authors:  Anthony G Doran; Kim Wong; Jonathan Flint; David J Adams; Kent W Hunter; Thomas M Keane
Journal:  Genome Biol       Date:  2016-08-01       Impact factor: 13.583

9.  What are we to think when results from mouse research contradict those from human experiments and clinical practice?

Authors:  G Schofield; G Henderson; C Crofts; S Thornley
Journal:  Nutr Diabetes       Date:  2016-08-15       Impact factor: 5.097

10.  A comprehensive and comparative phenotypic analysis of the collaborative founder strains identifies new and known phenotypes.

Authors:  Heike Kollmus; Helmut Fuchs; Christoph Lengger; Hamed Haselimashhadi; Molly A Bogue; Manuela A Östereicher; Marion Horsch; Thure Adler; Juan Antonio Aguilar-Pimentel; Oana Veronica Amarie; Lore Becker; Johannes Beckers; Julia Calzada-Wack; Lillian Garrett; Wolfgang Hans; Sabine M Hölter; Tanja Klein-Rodewald; Holger Maier; Philipp Mayer-Kuckuk; Gregor Miller; Kristin Moreth; Frauke Neff; Birgit Rathkolb; Ildikó Rácz; Jan Rozman; Nadine Spielmann; Irina Treise; Dirk Busch; Jochen Graw; Thomas Klopstock; Eckhard Wolf; Wolfgang Wurst; Ali Önder Yildirim; Jeremy Mason; Arturo Torres; Rudi Balling; Terry Mehaan; Valerie Gailus-Durner; Klaus Schughart; Martin Hrabě de Angelis
Journal:  Mamm Genome       Date:  2020-02-14       Impact factor: 2.957

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.